The portions depicted in broken line form are not considered part of the claimed design.
The portions depicted in broken line form are not considered part of the claimed design.
| Number | Name | Date | Kind |
|---|---|---|---|
| 7744644 | Weber et al. | Jun 2010 | B2 |
| D665079 | Zago | Aug 2012 | S |
| D665080 | Zago | Aug 2012 | S |
| 8353949 | Weber et al. | Jan 2013 | B2 |
| D723165 | Chanduszko | Feb 2015 | S |
| D723166 | Igaki | Feb 2015 | S |
| 9138512 | Ferrari et al. | Sep 2015 | B2 |
| D740427 | McDonnell | Oct 2015 | S |
| 20030055485 | Lee | Mar 2003 | A1 |
| 20110106239 | Goto | May 2011 | A1 |
| Entry |
|---|
| Feiring, AJ, “Below-the-Knee Drug-Eluting Stents,” Endovascular Today, pp. 65-72 (Aug. 2011). |
| U.S. Department of Health and Human Services Food and Drug Administration, “Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems,” Guidance for Industry and FDA Staff, pp. 1-55 (Apr. 18, 2010). |
| U.S. Department of Health and Human Services Food and Drug Administration, “Select Updates for Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems,” Guidance for Industry and Food and Drug Administration Staff, pp. 1-10 (Aug. 18, 2015). |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16287519 | Feb 2019 | US |
| Child | 29687850 | US |